Australian shares inch lower on virus, U.S. stimulus worries


Afterpay jumps nearly 5% on strong Q1 results

ANZ sees $376 million hit to H2 earnings

Financial index hits over two-week low

Oct 28 (Reuters) - Australian shares edged lower on Wednesday due to waning prospects of a U.S. stimulus deal and rising global cases of the novel coronavirus, although gains in local healthcare and tech stocks limited the benchmark's losses.

The S&P/ASX 200 index .AXJO dipped 0.1% to 6,047.6 by 0017 GMT, weighed down by financials and energy sub-indexes. The benchmark lost 1.7% on Tuesday.

Overnight, Wall Street closed lower after U.S. President Donald Trump acknowledged the much-needed COVID-19 stimulus, the cause of intense market volatility these past few weeks, would likely come after the Nov. 3 election, .N

Denting sentiment further, global cases of COVID-19 crossed 43.61 million, with the death toll at 1,160,278, a Reuters tally showed. In the United States, the disease has killed more than 225,000 and infected more than 8.7 million people.

Australia's heavyweight financial sub-index index .AXFJ fell 1% to lead losses and hit a two-week low. Australia and New Zealand Banking Group's ANZ.AX shares were the biggest drag.

Shares of the country's third largest lender slid 2.7% on revealing a $376 million hit to second-half earnings.

The other three of the "Big Four" banks traded 1.4% to 1.7% lower.

The ASX 200 Energy index .AXEJ fell 1.5%. Electricity retailer Origin Energy Ltd ORG.AX led the decline with its 2.6% fall, and fuel refiner Ampol Ltd ALD.AX dropped 2.3%.

The healthcare .AXHJ and tech indexes .AXIJ firmed 1.2% and 2.2%, respectively, to counter some of the losses on the benchmark.

Shares of medical device maker Resmed Inc RMD.AX jumped 4.3% to power healthcare stocks a day before the U.S.-based company's quarterly results where it's expected to record a jump in revenue.

Meanwhile, buy-now-pay-later favourite Afterpay Ltd's APT.AX stellar first-quarter results boosted its stock price by nearly 5%.

New Zealand's benchmark .NZ50 gained 0.4% or 57.9 points to 12,309.8.

Gains were driven by healthcare firms Fisher and Paykel Healthcare Corp Ltd FPH.NZ and Oceania Healthcare Ltd OCA.NZ, advancing 4.6% and 1.4%, respectively.

(Reporting by Anushka Trivedi in Bengaluru; editing by Uttaresh.V)

((; +918061823241;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.